GW788388 |
Inhibitor of TGFBR1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TGFBR1 |
|
|
Inhibitor
up to 1 uM, max 10 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - p38alpha: 7.2 uM
Potency Assay Off-Target:
In an in vitro panel of kinases, GW788388 only inhibited p38a >50% at 10 uM (panel included: P70S6K, ...
Selectivity Assessment Description:
In an in vitro panel of kinases, GW788388 only inhibited p38a >50% (IC50 of 7.28 µM) at 10 uM ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
In U2OS cells, GW788388 had no effect on BMP-induced Smad1/5 phosphorylation.
Potency Cellular
In Vitro
TGFBR1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Sprague Dawley rat, various mice
Dose: 2 mg/kg, 4 mg/kg
Route of delivery:
Intravenous, Oral
Plasma half life:
1.3 h (rat, IV)
Systemic clearance:
20 mL/min/kg (rat, IV)
Organ of interest (O):
mouse liver, mouse kidney
Target engagement assay:
In DMN-induced mouse models of liver disease and in chemically-induced mouse models of renal fibrosis, GW788388 inhibited TGF-beta-induced collagen IA1 mRNA expression. In db/db mouse model of diabetic retinopathy, GW788388 (2 mg/kg, oral) decreased TGF-beta-induced expression of extracellular matrix (ECM) mRNAs.
Reference: --
Chemical Information
| Molecular Formula | C25H23N5O2 |
| SMILEs | O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1 |
| InChI | InChI=1S/C25H23N5O2/c31-25(29-20-9-13-32-14-10-20)18-6-4-17(5-7-18)23-15-19(8-12-27-23)21-16-28-30-24(21)22-3-1-2-11-26-22/h1-8,11-12,15-16,20H,9-10,13-14H2,(H,28,30)(H,29,31) |
| Molecular weight | 425.19 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 55 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.